Practical Dermatology: Atopic Dermatitis

Addressing the Unique Challenges of AD Patients 

FDA Approves Ely Lilly’s AD Drug Ebglyss (Lebrikizumab)

ISDPA: Dr. Bhatia on JAK Inhibitors

ISDPA: Dr. Bhatia and Dr. Zirwas Discuss the Itchy Patient

Study Examines Association Between Childhood BMI and Risk of Developing IMSDs